Driehaus Capital Management’s Immunic IMUX Stock Holding History

Driehaus Capital Management’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,000	Closed	-$452K	–	395
2022 Q1	$452K	Sell	4,000 -6,000	-60%	-$695K	0.01%	344
2021 Q4	$957K	Sell	10,000 -20,000	-67%	-$1.8M	0.01%	311
2021 Q3	$2.65M	Buy	+30,000	New	+$2.95M	0.03%	315
2015 Q1	–	Sell	-73	Closed	-$723K	–	519
2014 Q4	$723K	Buy	73 +27	+59%	+$208K	0.03%	411
2014 Q3	$376K	Sell	46 -21	-31%	-$198K	0.01%	490
2014 Q2	$733K	Buy	+67	New	+$470K	0.02%	473

Other funds holding IMUX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Driehaus Capital Management's IMUX Position: Q2 2022 in Review

Driehaus Capital Management sold out of Immunic (IMUX) in Q2 2022, closing a stake of 4,000 shares — an estimated $452K sold.

Driehaus Capital Management first reported a position in IMUX in Q2 2014 and held it in 6 quarters. The position peaked at $2.65M in Q3 2021. 72 funds tracked by Wall St. Rank hold IMUX as of Q2 2022.

Driehaus Capital Management reported no remaining Immunic position as of Q2 2022 after selling out during the quarter.
Driehaus Capital Management sold 4,000 Immunic shares in Q2 2022, an estimated $452K.
Driehaus Capital Management first reported a position in Immunic in Q2 2014 and held it in 6 quarters.
Driehaus Capital Management's Immunic position peaked at $2.65M in Q3 2021.
72 funds tracked by Wall St. Rank held Immunic as of Q2 2022.

Based on Driehaus Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.